← Back to all posts
🧬

A rare disease reveals a hidden flaw in the immune system

For decades, scientists thought they understood what drives dangerous inflammation in mevalonate kinase deficiency, or MKD. Now, researchers at the Garvan Institute have found that natural killer cells also play a key role: in people with MKD, these cells struggle to destroy infected cells and instead release excess inflammatory signals. This finding reshapes the prevailing explanation of the disease and may help account for why existing treatments do not work well for some patients. It also points to JAK inhibitors as a promising avenue for future studies and more targeted treatment.
Read the original article ↗
Share